Legal & General Group PLC Maxcyte, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 107,472 shares of MXCT stock, worth $367,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,472

Previous 107,472 -0.0%

Holding current value

$367,554

Previous $418,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.68 - $5.06 $14,267 - $19,617	3,877 Added 3.74%	107,472 $418,000
Q2 2024 Aug 14, 2024	BUY	$3.63 - $5.0 $68,835 - $94,815	18,963 Added 22.41%	103,595 $406,000
Q1 2024 May 14, 2024	BUY	$3.94 - $5.38 $15,011 - $20,497	3,810 Added 4.71%	84,632 $354,000
Q4 2023 Feb 15, 2024	BUY	$2.6 - $5.24 $17,466 - $35,202	6,718 Added 9.07%	80,822 $379,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $5.1 $43,149 - $72,868	14,288 Added 23.89%	74,104 $231,000
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $115,526 - $167,497	31,308 Added 109.82%	59,816 $274,000
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $7,193 - $10,513	1,785 Added 6.68%	28,508 $141,000
Q4 2022 Feb 14, 2023	BUY	$4.92 - $7.4 $5,653 - $8,502	1,149 Added 4.49%	26,723 $145,000
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $787,718 - $1.13 Million	-174,274 Reduced 87.2%	25,574 $166,000
Q2 2022 Aug 22, 2022	SELL	$3.59 - $6.81 $7,402 - $14,042	-2,062 Reduced 1.02%	199,848 $942,000
Q1 2022 May 16, 2022	SELL	$5.26 - $10.84 $1.08 Million - $2.23 Million	-205,552 Reduced 50.45%	201,910 $1.43 Million
Q4 2021 Feb 14, 2022	SELL	$8.87 - $12.94 $3.93 Million - $5.73 Million	-443,174 Reduced 52.1%	407,462 $4.16 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $10.4 Million - $14.6 Million	850,636 New	850,636 $10.4 Million

Others Institutions Holding MXCT

# of Institutions

124

Shares Held

65.6M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $348M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Maxcyte, Inc. Transaction History